Atlas Trials

Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel Disease

Clinical trial NCT06643013 · RECRUITING

Trial details

NCT number
NCT06643013
Sponsor
Imperial College London
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Cerebral Small Vessel Disease
Start date
2024-10-01
Primary completion
2028-04-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.